Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-11-23

Clinical Trial Update: A RCT of a Combination of Analgesics for Pain Management in Children With a Suspected Fracture [Phase 4]

View source ↗

Summary

A phase 4 randomized trial evaluating a combination of analgesics for pediatric pain management in suspected fractures has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENTANYL (FENTANYL)
  • Ibuprofen (IBUPROFEN)

Snippet

Sponsor: St. Justine's Hospital | Conditions: Emergency Service, Hospital, Child/Adolescent Problem | Phase 4 | Status: WITHDRAWN